|
Robert A. Ingram was appointed Chairman of OSI Pharmaceuticals Board in January 2003. Mr. Ingram is Vice Chairman of Pharmaceuticals, GlaxoSmithKline, acting as special advisor to the Group and representing GSK on the board of the US Pharmaceuticals Research and Manufacturers' Association (PhRMA) as of January 2003. He is a member of the Corporate Executive Team. Mr. Ingram retired from his position as Chief Operating Officer and President, Pharmaceutical Operations, for GSK, as of 31 December 2002.
Mr. Ingram began his career in the pharmaceutical industry as a sales representative for the company that would later become Merrell Dow Pharmaceuticals. He advanced rapidly through sales management at Merrell Dow and into government and public affairs. He left Merrell Dow in 1985 as Vice President of Public Affairs to become Vice President of Government Affairs at Merck & Co. Inc. In 1988, he was promoted to President of Merck Frosst Canada Inc. In 1990, Mr. Ingram left Merck to join Glaxo Inc., Glaxo plc's US subsidiary, as Executive Vice President of Administrative and Regulatory Affairs and assumed a series of increasingly responsible positions, including Group Vice President. He was named Executive Vice President in January 1993, President and Chief Operating Officer in June 1993, President and Chief Executive Officer in March 1994, and Chairman in January 1999.
As an executive director of Glaxo Wellcome plc, Mr. Ingram held responsibility for operations in North America and Latin America. He was appointed to the global Company's Board in May 1995. In October 1997, he became Chief Executive of Glaxo Wellcome plc with responsibility for worldwide business operations, and added the position of Chairman to his responsibilities at Glaxo Wellcome Inc.
Mr. Ingram graduated from Eastern Illinois University with a BS degree in Business Administration. He serves on the Board of Directors of the Wachovia Corporation, Nortel Networks, Lowe's Companies and Misys plc (non-executive Director).
In addition to his professional responsibilities, Mr. Ingram was asked by former US President George H. Bush to form and chair the CEO Roundtable on Cancer. He also currently serves as President of the American Cancer Society Foundation, and is a member of numerous other civic and professional organizations. Bob is also a frequent speaker at industry, pharmacy and government seminars. | 